| Literature DB >> 32335200 |
Wanqiu Tan1, Fengyi Hao2, Roger S McIntyre3, Li Jiang2, Xiaojiang Jiang4, Ling Zhang2, Xinling Zhao2, Yiran Zou2, Yirong Hu2, Xi Luo2, Zhisong Zhang4, Andre Lai5, Roger Ho6, Bach Tran7, Cyrus Ho8, Wilson Tam9.
Abstract
This study aimed to quantify the immediate psychological effects and psychoneuroimmunity prevention measures of a workforce returning to work during the COVID-19 epidemic. Workforce returning to work was invited to complete an online questionnaire regarding their attitude toward the COVID-19 epidemic and return-to-work along with psychological parameters including the Impact of Event Scale-Revised, Depression, Anxiety, Stress Scale- 21 (DASS-21) and Insomnia Severity Index (ISI). Psychoneuroimmunity prevention measures include precautions at personal and organization levels. From 673 valid questionnaires, we found that 10.8% of respondents met the diagnosis of post-traumatic stress disorder (PTSD) after returning to work. The respondents reported a low prevalence of anxiety (3.8%), depression (3.7%), stress (1.5%) and insomnia (2.3%). There were no significant differences in the severity of psychiatric symptoms between workers/technicians and executives/managers. >95% reported psychoneuroimmunity prevention measures including good ventilation in the workplace and wore a face mask as protective. Factors that were associated with the severity of psychiatric symptoms in the workforce were marital status, presence of physical symptom, poor physical health and viewing return to work as a health hazard (p < 0.05). In contrast, personal psychoneuroimmunity prevention measures including hand hygiene and wearing face masks as well as organizational measures including significant improvement of workplace hygiene and concerns from the company were associated with less severe psychiatric symptoms (p < 0.05). Contrary to expectations, returning to work had not caused a high level of psychiatric symptoms in the workforce. The low prevalence of psychiatric symptoms could be due to confidence instilled by psychoneuroimmunity prevention measures before the resumption of work. Our findings would provide information for other countries during the COVID-19 pandemic.Entities:
Keywords: Anxiety; COVID-19; Coronavirus; Depression; Insomnia; Occupational health mental health; PTSD; Pandemic; Quarantine; Stress; Suicide; Workers; Workforce
Mesh:
Year: 2020 PMID: 32335200 PMCID: PMC7179503 DOI: 10.1016/j.bbi.2020.04.055
Source DB: PubMed Journal: Brain Behav Immun ISSN: 0889-1591 Impact factor: 7.217
The IES-R, DASS-21 and ISI scores of study respondents after they were approved to return to work.
| All respondents (n=673) | Workers and Technical staff (n= 551) | Management and executive staff (n = 122) | P-value | |
|---|---|---|---|---|
| Impact of Event Scale-Revised (IES-R) | ||||
| Mean IES-R score (SD) | 9.8 (11.0) | 9.60 (10.99) | 10.58(10.93) | p = 0.374 |
| Presence of PTSD symptoms | ||||
| No PTSD like symptoms (17 or below) | 547 (81.3%) | 451 (81.9%) | 96 (78.7%) | p=0.477 |
| Presence of PTSD like symptoms (18 - 23) | 53 (7.9%) | 44 (8.0%) | 9 (7.4%) | |
| Diagnosis of PTSD (24 or above) | 73 (10.8%) | 56 (10.2%) | 17 (13.9%) | |
| Depression, Anxiety, Stress and Stress Scale – 21 (DASS - 21) | ||||
| Mean DASS-21 Anxiety score (SD) | 1.6 (3.7) | 1.62 (3.89) | 1.51 (2.91) | p = 0.760 |
| DASS-21 (Anxiety) | ||||
| No (0-7) | 632 (93.9%) | 519 (94.2%) | 113 (92.6% | P=0.378 |
| Mild (8-9) | 15 (2.2%) | 11 (2.0%) | 4 (3.3%) | |
| Moderate (10-14) | 17 (2.5%) | 12 (2.2%) | 5 (4.1%) | |
| Severe (15-19) | 4 (0.6%) | 4 (0.7%) | 0 (0.0%) | |
| Extremely Severe (20+) | 5 (0.7%) | 5 (0.9%) | 0 (0.0%) | |
| Mean DASS-21 Depression score (SD) | 2.1 (4.5) | 2.59 (4.86) | 2.57 (4.71) | p=0.977 |
| DASS-21 (Depression) | ||||
| No (0-9) | 633 (94.1%) | 522 (94.7%) | 111 (91.0%) | p=0.127 |
| Mild (10-13) | 15 (2.2%) | 9 (1.6%) | 6 (4.9%) | |
| Moderate (14-20) | 19 (2.8%) | 14 (2.5%) | 5 (4.1%) | |
| Severe (21-27) | 2 (0.3%) | 2 (0.4%) | 0 (0.0%) | |
| Extremely Severe (28+) | 4 (0.6%) | 4 (0.7%) | 0 (0.0%) | |
| Mean DASS-21 Stress score (SD) | 2.6 (4.8) | 1.11 (0.51) | 1.13 (0.44) | p = 0.440 |
| DASS-21 (Stress) | ||||
| No (0-14) | 651 (96.7%) | 533 (96.7%) | 118(96.7%) | P=0.865 |
| Mild (15-18) | 12 (1.8%) | 9 (1.6%) | 3 (2.5%) | |
| Moderate (19-25) | 6 (0.9%) | 5 (0.9%) | 1 (0.8%) | |
| Severe (26-33) | 2 (0.3%) | 2 (0.4%) | 0 (0.0%) | |
| Extremely Severe (34+) | 2 (0.3%) | 2 (0.4%) | 0 (0.0%) | |
| Insomnia Severity Index (ISI) | ||||
| Mean ISI score (SD) | 3.3 (4.4) | 3.74 (4.37) | 4.07 (4.41) | p=0.440 |
| No clinically significant insomnia (0-7) | 570 (84.7%) | 473 (86.5%) | 97 (80.2%) | p=0.217 |
| Subthreshold insomnia (8-14) | 82 (12.2%) | 61 (11.2%) | 21 (17.4%) | |
| Moderately severe clinical insomnia (15-21) | 13 (1.9%) | 10 (1.8%) | 3 (2.5%) | |
| Severe clinical insomnia (22-28) | 3 (0.4%) | 3 (0.5%) | 0 (0.0%) | |
Other psychiatric symptoms reported by respondents during the COVID-19 epidemic.
| Other psychiatric symptoms | All respondents (n=673) | Workers and Technical staff (n= 551) | Management and executive staff (n = 122) | P - value |
|---|---|---|---|---|
| Worried about own physical health | ||||
| No worry | 446 (66.3%) | 371 (67.3%) | 75 (61.5%) | 0.307 |
| Mild worry | 146 (21.7%) | 116 (21.1%) | 30 (24.6%) | |
| Moderate worry | 48 (7.1%) | 37 (6.7%) | 11 (9.0%) | |
| Severe worry | 17 (2.5%) | 12 (2.2%) | 5 (4.1%) | |
| Very severe worry | 16 (2.4%) | 15 (2.7%) | 1 (0.8%) | |
| Experience of discrimination during COVID-19 epidemic | ||||
| No discrimination | 629 (93.5%) | 511 (92.7%) | 118 (96.7% | |
| Mild discrimination | 24 (3.6%) | 21 (3.8%) | 3 (2.5%) | 0.435 |
| Moderate discrimination | 10 (1.5%) | 10 (1.8%) | 0 (0.0%) | |
| Serious discrimination | 6 (0.9%) | 5 (0.9%) | 1 (0.8%) | |
| Very serious discrimination | 4 (0.6%) | 4 (0.7%) | 0 (0.0%) | |
| Auditory hallucination | ||||
| No auditory hallucination | 652 (96.9%) | 534 (96.9%) | 118 (86.7%) | 0.834 |
| Mild auditory hallucination | 14 (2.1%) | 11 (2.0%) | 3 (2.5%) | |
| Moderate auditory hallucination | 3 (0.4%) | 2 (0.4%) | 1 (0.8%) | |
| Severe auditory hallucination | 2 (0.3%) | 2 (0.4%) | 0 (0.0%) | |
| Very severe auditory hallucination | 2 (0.3%) | 2 (0.4%) | 0 (0.0%) | |
| Paranoid Idea | ||||
| No paranoid idea | 658 (97.8%) | 539 (97.8%) | 119 (97.5%) | 0.903 |
| Mild paranoid idea | 6 (0.9%) | 5 (0.9%) | 1 (0.8%) | |
| Moderate paranoid idea | 4 (0.6%) | 3 (0.5%) | 1 (0.8%) | |
| Severe paranoid idea | 3 (0.4%) | 2 (0.4%) | 1 (0.8%) | |
| Very severe paranoid idea | 2 (0.3%) | 2 (0.4%) | 0 (0.0%) | |
| Anger and impulsivity | ||||
| No anger and impulsivity | 598 (88.9%) | 491 (89.1%) | 107 (87.7%) | 0.491 |
| Mild anger and impulsivity | 51 (7.6%) | 42 (7.6%) | 9 (7.4%) | |
| Moderate anger and impulsivity | 18 (2.7%) | 13 (2.4%) | 5 (4.1%) | |
| Severe anger and impulsivity | 2 (0.3%) | 1 (0.2%) | 1 (0.8%) | |
| Very severe anger and impulsivity | 4 (0.6%) | 4 (0.7%) | 0 (0.0%) | |
| Alcohol use | ||||
| No alcohol use | 642 (95.4%) | 525 (95.3%) | 117 (95.9%) | 0.922 |
| Mild alcohol use | 26 (3.9%) | 22 (4.0%) | 4 (3.3%) | |
| Moderate alcohol use | 4 (0.6%) | 3 (0.5%) | 1 (0.8%) | |
| Severe alcohol use | 1 (0.1%) | 1 (0.2%) | 0 (0.0%) | |
| Very severe alcohol use | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
| Suicidal ideation | ||||
| No suicidal ideation | 662 (98.4%) | 541 (98.2%) | 121 (99.2%) | 0.839 |
| Mild suicidal ideation | 8 (1.2%) | 7 (1.3%) | 1 (0.8%) | |
| Moderate suicidal ideation | 2 (0.3%) | 2 (0.4%) | 0 (0.0%) | |
| Severe suicidal ideation | 1 (0.1%) | 1 (0.2%) | 0 (0.0%) | |
| Very severe suicidal ideation | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
| The intention of hurting others | ||||
| No intention of hurting others | 664 (98.7%) | 545 (98.9%) | 119 (97.5%) | 0.487 |
| The mild intention of hurting others | 5 (0.7%) | 3 (0.5%) | 2 (1.6%) | |
| The moderate intention of hurting others | 2 (0.3%) | 1 (0.2%) | 1 (0.8%) | |
| The severe intention of hurting others | 1 (0.1%) | 1 (0.2%) | 0 (0.0%) | |
| The very severeintention of hurting others | 1 (0.1%) | 1 (0.2%) | 0 (0.0%) | |
| Worrying about young children | ||||
| No worries | 451 (67.0%) | 370 (67.2 %) | 81 (66.4%) | 0.028* |
| Mild worries | 123 (18.3%) | 93 (16.9%) | 30 (24.6%) | |
| Moderate worries | 43 (6.4%) | 38 (6.9%) | 5 (4.1%) | |
| Severe worries | 28 (4.2%) | 22 (4.0%) | 6 (4.9%) | |
| Very severe worries | 28 (4.2%) | 28 (5.1%) | 0 (0.0%) | |
*p < 0.05
Views of respondents towards the strict quarantine and lockdown before returning to work.
| All respondents (n=673) | Workers and Technical staff (n= 551) | Management and executive staff (n = 122) | P-value | |
|---|---|---|---|---|
| Do you think the strict quarantine and lockdown is useful to stop the spread of the virus? | ||||
| No | 50 (7.4%) | 47 (8.5%) | 3 (2.5%) | 0.08 |
| A little bit | 193 (28.7%) | 163 (29.6%) | 30 (24.6%) | |
| Moderate | 73 (10.8%) | 58 (10.5%) | 15 (12.3%) | |
| Useful | 189 (28.1%) | 147 (26.7%) | 42 (34.4%) | |
| Extremely useful | 168 (25.0%) | 136 (24.7%) | 32 (26.2%) | |
| Do you think the 2-week duration of the closure of the workplace was useful to stop the spread of COVID-19? | ||||
| No | 43 (6.4%) | 40 (7.3%) | 3 (2.5%) | 0.033* |
| A little bit | 123 (18.3%) | 106 (19.2%0 | 17 (13.9%) | |
| Moderate | 79 (11.7%) | 68 (12.3%) | 11 (9.0%) | |
| Useful | 221 (32.8%) | 169 (30.7%) | 52 (42.6%) | |
| Extremely useful | 207 (30.8%) | 168 (30.5%) | 39 (32.0%) | |
| Do you think returning to work is a threat to your life during the COVID-19 epidemic? | ||||
| None | 313 (46.5%) | 265 (48.1%) | 48 (39.3%) | 0.157 |
| A little bit | 260 (38.6%) | 207 (37.6%) | 53 (43.4%) | |
| Moderate | 70 (10.4%) | 52 (9.4%) | 18 (14.8%) | |
| Serious | 22 (3.3%) | 20 (3.6%) | 2 (1.6%) | |
| Extremely serious | 8 (1.2%) | 7 (1.3%) | 1 (0.8%) | |
| Do you think the workplace hygiene has improved after the COVID-10 outbreak? | ||||
| Workplace hygiene was enough before the | 166 (24.7%) | 131 (23.8%) | 35 (28.7%) | 0.072 |
| COVID-19 outbreak | ||||
| Substantial improvement since the outbreak | 182 (27.0%) | 141 (25.6%) | 41 (33.6%) | |
| Moderate improvement since the outbreak | 176 (26.2%) | 150 (27.2%) | 26 (21.3%) | |
| Small improvement since the outbreak | 120 (17.8%) | 103 (18.7%) | 17 (13.9%) | |
| Need further improvement | 17 (2.5%) | 17 (1.3%) | 0 (0.0%) | |
| Do you think your company cares and concerns about your health? | ||||
| No care and concern at all | 18 (2.7%) | 15 (2.7%) | 3 (2.5%) | 0.107 |
| Little care and concern | 6 (0.9%) | 3 (0.5%) | 3 (2.5%) | |
| Neutral or no comment | 99 (14.7%) | 87 (15.8%) | 12 (9.8%) | |
| Moderate level of care and concern | 228 (33.9%) | 189 (34.3%) | 39 (32.0%) | |
| High level of care and Concern | 322 (47.8%) | 257 (46.6%) | 65 (53.3%) | |
*p < 0.05
Views of respondents towards psychoneuroimmunity preventive measures when returning to work during COVID-19 epidemic.
| Participants (n=673) | Workers and Technical staff (n= 551) | Management and executive staff (n = 122) | P-value | |
|---|---|---|---|---|
| Avoidance of sharing utensils (e.g., chopsticks) during meals | ||||
| Always | 569 (84.5%) | 473 (85.8%) | 96 (78.7%) | 0.040* |
| Most of the time | 51 (7.6%) | 41 (7.4%) | 10 (8.2%) | |
| Sometime | 15 (2.2%) | 13 (2.4%) | 2 (1.6%) | |
| Rarely | 15 (2.2%) | 9 (1.6%) | 6 (4.9%) | |
| Never | 23 (3.4%) | 15 (2.7%) | 8 (6.6%) | |
| Proper handwashing with soap and water | ||||
| Always | 535 (79.5%) | 438 (79.5%) | 97 (79.5%) | 0.048* |
| Most of the time | 100 (14.9%) | 80 (14.5%) | 20 (16.4%) | |
| Sometime | 27 (4.0%) | 25 (4.5%) | 2 (1.6%) | |
| Rarely | 6 (0.9%) | 6 (1.1%) | 0 (0.0%) | |
| Never | 5 (0.7%) | 2 (0.4%) | 3 (2.5%) | |
| Washing hands immediately after coughing, rubbing the nose, or sneezing | ||||
| Always | 486 (72.2%) | 396 (71.9%) | 90 (73.8%) | 0.43 |
| Most of the time | 106 (15.8%) | 90 (16.3%) | 16 (13.1%) | |
| Sometime | 50 (7.4%) | 39 (7.1%) | 11 (9.0%) | |
| Rarely | 22 (3.3%) | 20 (3.6%) | 2 (1.6%) | |
| Never | 9 (1.3%) | 6 (1.1%) | 3 (2.5%) | |
| Washing hands after touching a contaminated object | ||||
| Always | 548 (81.4%) | 449 (81.5%) | 99 (81.1%) | 0.037* |
| Most of the time | 89 (13.2%) | 72 (13.1%) | 17 (13.9%) | |
| Sometime | 19 (2.8%) | 17 (3.1%) | 2 (1.6%) | |
| Rarely | 10 (1.5%) | 10 (1.8%) | 0 (0.0%) | |
| Never | 7 (1.0%) | 3 (0.5%) | 4 (3.3%) | |
| Covering mouth when coughing and sneezing | ||||
| Always | 525 (78.0%) | 426 (77.3%) | 99 (81.1%) | 0.073 |
| Most of the time | 82 (12.2%) | 70 (12.7%) | 12 (9.8%) | |
| Sometime | 40 (5.9%) | 35 (6.4%) | 5 (4.1%) | |
| Rarely | 15 (2.2%) | 14 (2.5%) | 1 (0.8%) | |
| Never | 11 (1.6%) | 6 (1.1%) | 5 (4.1%) | |
| Wearing a face mask regardless of the presence or absence of symptoms | ||||
| Always | 590 (87.7%) | 480 (87.1%) | 110 (90.2%) | 0.305 |
| Most of the time | 54 (8.0%) | 47 (8.5%) | 7 (5.7%) | |
| Sometime | 11 (1.6%) | 11 (2.0%) | 0 (0.0%) | |
| Rarely | 12 (1.8%) | 9 (1.6%) | 3 (2.5%) | |
| Never | 6 (0.9%) | 4 (0.7%) | 2 (1.6%) | |
| Having good ventilation in the workplace | ||||
| Always | 596 (88.6%) | 489 (88.7%) | 107 (87.7%) | 0.737 |
| Most of the time | 62 (9.2%) | 51 (9.3%) | 11 (9.0%) | |
| Sometime | 9 (1.3%) | 6 (1.1%) | 3 (2.5%) | |
| Rarely | 2 (0.3%) | 2 (0.4%) | 0 (0.0%) | |
| Never | 4 (0.6%) | 3 (0.5%) | 1 (0.8%) | |
*p < 0.05.
Multiple linear regression analysis^ between demographic, psychoneuroimmunity preventive measures and immediate mental health of respondents when returning to work during COVID-19 epidemic (n = 673).
| Variables | Mean IES-R score β (95% CI) | Mean DASS – 21 anxiety score β (95% CI) | Mean DASS – 21 depression score β (95% CI) | Mean DASS – 21 stress score β (95% CI) | Mean ISI scoreβ (95% CI) |
|---|---|---|---|---|---|
| Marital Status | |||||
| Single | Reference group | Reference group | Reference group | Reference group | |
| Married | 1.80 (0.22, 3.37), p = 0.025* | −0.60 (−1.15, −0.05), p = 0.031* | −0.66 (−1.33, 0.01), p = 0.054 | −0.15 (−0.78, 0.48), p = 0.640 | |
| Divorced/ Separated/ Widowed | 5.63 (1.42, 9.84), p = 0.009* | 1.54 (0.55, 3.03), p = 0.042* | 2.05 (0.22, 3.88), p = 0.028* | 2.53 (0.81, 4.25), p = 0.004* | |
| † Recent physical symptoms in the past 14 weeks | |||||
| Yes | 1.43 (0.54, 2.32), p = 0.002* | 1.35 (0.25, 2.45), p = 0.016* | 1.49 (0.35, 2.64), p = 0.011* | 1.30 (0.26, 2.33), p = 0.014* | |
| No | Reference group | Reference group | Reference group | Reference group | |
| Self-reported health | |||||
| Poor | 12.2 (5.93, 18.5), p < 0.001** | Non-Significant | 3.28 (0.45, 6.11), p = 0.023* | 4.12 (1.55, 6.68), p = 0.002* | |
| Normal | 2.51 (0.82, 4.19), p = 0.004* | 1.04 (0.30, 1.77), p = 0.006* | 1.23 (0.46, 2.00), p = 0.002* | 1.56 (0.87, 2.25), p < 0.001** | |
| Good | Reference group | Reference group | Reference group | Reference group | |
| Number of days since the return to work (24 Feb 2020) | |||||
| Not yet return to work | 2.33 (0.42, 4.20), p = 0.015* | ||||
| Within 7 days | 2.58 (0.32, 4.84), p = 0.026* | ||||
| 8 to 14 days | 2.58 (−0.12, 5.28), p = 0.061 | ||||
| No information | 2.99 (−0.22, 6.19), p = 0.068 | ||||
| 15 or more days | Reference group | ||||
| Improvement in workplace’s hygiene after the COVID-19 outbreak | |||||
| Workplace hygiene was good enough before the COVID-19 outbreak | Reference group | Reference group | |||
| Substantial improvement since the outbreak | 1.58 (−0.56, 3.71), p = 0.147* | −0.20 (−1.18, 0.79), p = 0.696 | |||
| Moderate Improvement since the outbreak | 3.31 (1.11, 5.50), p = 0.003* | 0.64 (−0.37, 1.65), p = 0.211 | |||
| Little improvement since the outbreak | 5.74 (3.28, 8.20), p < 0.001** | 1.21 (0.08, 2.34), p = 0.037 | |||
| Need further improvement | 9.79 (3.91, 15.7), p = 0.001** | 2.55 (−0.13, 5.23), p = 0.062 | |||
| Do you think returning to work is a health hazard? | |||||
| No | Reference group | Reference group | Reference group | Reference group | Reference group |
| Small | 3.91 (2.20, 5.63), p < 0.001** | 0.47 (−0.11, 1.05), p = 0.111 | 0.24 (−0.48, 0.96), p = 0.516 | 1.02 (0.22, 1.81) p = 0.012* | 1.18 (0.50, 1.85), p = 0.001* |
| Moderate | 5.21 (2.52, 7.89), p < 0.001** | 0.97 (0.05, 1.89), p = 0.039* | 0.92 (−0.21, 2.05), p = 0.111 | 1.53 (0.31, 2.75), p = 0.014* | 1.84 (0.77, 2.91), p = 0.001* |
| Serious | 10.3 (5.81, 14.77), p < 0.001** | 3.66 (2.14, 5.18), p < 0.001** | 3.05 (1.19, 4.90), p = 0.001** | 3.81 (1.79, 5.83), p < 0.001** | 3.57 (0.92, 6.57), p < 0.001** |
| Extremely Serious | 12.3 (5.17, 19.5), p = 0.001** | 7.31 (4.85, 9.76), p < 0.001** | 7.83 (4.84, 10.8), p < 0.001** | 7.70 (4.43, 10.97), p < 0.001** | 3.75 (0.92, 6.57), p = 0.009* |
| Do you think your company cares about your health? | |||||
| No | −1.93(−3.87, 0.01), p = 0.051 | ||||
| Not much | Non-Significant | ||||
| Neutral | Non-Significant | ||||
| Moderate | 0.83 (0.14, 1.53), p = 0.019* | ||||
| Care a lot | Reference group | ||||
| Do you cover your mouth while coughing? | |||||
| Always | −4.13 (−8.09, −0.17), p = 0.041* | ||||
| Most of the time | Non-Significant | ||||
| Sometime | Non-Significant | ||||
| Never/Rarely | Reference group | ||||
| Do you wash your hands after coughing? | |||||
| Always | −2.27 (−3.54, −0.99), p = 0.001* | −3.18 (−4.74, −1.63), p < 0.001** | −1.86 (−3.33, −0.39),p = 0.013* | ||
| Most of the time | −1.60 (−3.00, −0.21), p = 0.025* | −2.71 (−4.41, −1.01), p = 0.002* | Non-Significant | ||
| Sometime | Non-Significant | −2.35 (−4.26, −0.44), p = 0.016* | Non-Significant | ||
| Never/Rarely | Reference group | Reference group | Reference group | ||
| Do you think the 2-week duration of the closure of the workplace was useful to stop the spread of COVID-19 before returning to work? | |||||
| Not useful | Reference | Reference | |||
| Little usefulness | 1.36 (−0.13, 2.86), p = 0.074 | 1.53 (−0.08, 3.14), p = 0.063 | |||
| Moderate usefulness | 2.48 (0.86, 4.10), p = 0.003* | 3.29 (1.58, 5.01), p < 0.001** | |||
| Very useful | 0.86 (−0.58, 2.29), p = 0.241 | 1.08 (−0.46, 2.62), p = 0.168 | |||
| Extremely useful | 1.19 (−0.23, 2.62), p = 0.101 | 1.61 (0.08, 3.14), p = 0.039* | |||
*p < 0.05, p < 0.001**.
†Recent physical symptoms in the past 14 days include fever, chills, headache, myalgia, cough, difficulty in breathing, dizziness, coryza, sore throat, nausea, vomiting or diarrhea.
^All the regressions included demographics, occupational health and personal protection measure variables as independent variables and backward selection method was then applied to remove all insignificant variables.